Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (881-890 of 1,142) with videos related to

Pageof 115
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2008
Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severityZ Sternberg, B Weinstock-Guttman, D Hojnacki, et al.
Molecular Neuropsychiatry|March 10, 2017
Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to ClozapineDanielle L Taylor, Arun K Tiwari, Jeffrey A Lieberman, et al.
Medical Education|November 13, 2010
Effects of comprehensive educational reforms on academic success in a diverse student bodySteven A Lieberman, Michael A Ainsworth, Gregory K Asimakis, et al.
Journal of Clinical Psychopharmacology|February 1, 1991
The prevalence of tardive dyskinesiaM G Woerner, J M Kane, J A Lieberman, et al.
The Journal of Reproductive Medicine|May 1, 1977
Laparoscopic sterilization with spring-loaded clips: double-puncture techniqueB A Lieberman, A G Gordon, J F Bostock, et al.
Schizophrenia Research|February 13, 2001
Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophreniaM Masellis, V S Basile, H Y Meltzer, et al.
The American Journal of Psychiatry|July 13, 2013
Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorderL Fredrik Jarskog, Robert M Hamer, Diane J Catellier, et al.
The Journal of Clinical Psychiatry|April 2, 2016
A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective DisorderJoshua T Kantrowitz, Zafar Sharif, Alice Medalia, et al.
Psychopharmacology|April 15, 2005
Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populationsRudi Hwang, Takahiro Shinkai, Vincenzo De Luca, et al.
Archives of General Psychiatry|March 17, 1999
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorderD Robinson, M G Woerner, J M Alvir, et al.
Pageof 115

Showing results (881-890 of 1,142) with videos related to

Sort By:
Pageof 115
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2008
Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severityZ Sternberg, B Weinstock-Guttman, D Hojnacki, et al.
Molecular Neuropsychiatry|March 10, 2017
Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to ClozapineDanielle L Taylor, Arun K Tiwari, Jeffrey A Lieberman, et al.
Medical Education|November 13, 2010
Effects of comprehensive educational reforms on academic success in a diverse student bodySteven A Lieberman, Michael A Ainsworth, Gregory K Asimakis, et al.
Journal of Clinical Psychopharmacology|February 1, 1991
The prevalence of tardive dyskinesiaM G Woerner, J M Kane, J A Lieberman, et al.
The Journal of Reproductive Medicine|May 1, 1977
Laparoscopic sterilization with spring-loaded clips: double-puncture techniqueB A Lieberman, A G Gordon, J F Bostock, et al.
Schizophrenia Research|February 13, 2001
Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophreniaM Masellis, V S Basile, H Y Meltzer, et al.
The American Journal of Psychiatry|July 13, 2013
Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorderL Fredrik Jarskog, Robert M Hamer, Diane J Catellier, et al.
The Journal of Clinical Psychiatry|April 2, 2016
A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective DisorderJoshua T Kantrowitz, Zafar Sharif, Alice Medalia, et al.
Psychopharmacology|April 15, 2005
Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populationsRudi Hwang, Takahiro Shinkai, Vincenzo De Luca, et al.
Archives of General Psychiatry|March 17, 1999
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorderD Robinson, M G Woerner, J M Alvir, et al.
Pageof 115